Evidence map›Paper›PMID 30646817›Full record

ArticlePrion2019

The prion 2018 round tables (I): the structure of PrP

Ilia V Baskakov, Byron Caughey, Jesús R Requena, Alejandro M Sevillano, Witold K Surewicz, Holger Wille

Abstract read
In one paragraph

Article in Prion, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. N-Terminal Regions of Prion Protein: Functions and Roles in Prion Diseases.International journal of molecular sciences · 2020
    Review
  11. Article
  12. The protean prion protein.PLoS biology · 2020
    Article
  13. Immunotherapy against Prion Disease.Pathogens (Basel, Switzerland) · 2020
    Review
  14. Modeling PrPFrontiers in bioengineering and biotechnology · 2020
    Article
  15. Prion protein-Semisynthetic prion protein (PrP) variants with posttranslational modifications.Journal of peptide science : an official publication of the European Peptide Society · 2019
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ilia V Baskakova Center for Biomedical Engineering and Technology and Department of Anatomy and Neurobiology , University of Maryland School of Medicine , Baltimore , MD , USA.
Byron Caugheyb Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories , National Institute of Allergy and Infectious Diseases, National Institutes of Health , Hamilton , MT , USA.
Jesús R Requenac CIMUS Biomedical Research Institute and Department of Medical Sciences , University of Santiago de Compostela-IDIS, Santiago de Compostela , Spain.
Alejandro M Sevillanod Departments of Pathology and Medicine , University of California San Diego , La Jolla , CA , USA.
Witold K Surewicze Departments of Pathology, and of Physiology and Biophysics , Case Western Reserve University , Cleveland , OH , USA.
Holger Willef Department of Biochemistry and Centre for Prions and Protein Folding Diseases , University of Alberta , Edmonton , AB , Canada.

Funding

Self-Propagating Mechanism of Prion DiseasesR01NS045585 · NINDS · UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE · PI Ilia V Baskakov · 2003 to 2026
$9.6M
Structures and Activities of Prions and Prion Proteins ZIAAI000580 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CAUGHEY, BYRON · 2009 to 2025
$8.9M
Neuropathology Core - P GambettiP01AI106705 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI GAMBETTI, PIERLUIGI · 2014 to 2018
$7.7M
Structural correlates of prion strain, phenotype and infectivity in human prion dR01NS083687 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI GAMBETTI, PIERLUIGI, SUREWICZ, WITOLD K · 2014 to 2018
$2.9M
Replication mechanism of human prionsR01NS103848 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI SAFAR, JIRI G., SUREWICZ, WITOLD K · 2018 to 2022
$2.6M
NIAID NIH HHS P01 AI106705NINDS NIH HHS R01 NS045585NINDS NIH HHS R01 NS083687NINDS NIH HHS R01 NS103848
6 · The paper itself

Abstract

Understanding the structure of PrP

Indexed as

AmyloidAnimalsGlycosylationHumansMiceModels, BiologicalModels, MolecularPrPSc ProteinsAmyloidPrPSc Proteins4-rung β-solenoidcryo-electron microscopyPIRIBSPrion2018PrP23-144 infectious amyloidPrP structurePrP syalilationsolid state NMR

Identifiers

PMID30646817
PMCPMC6422368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.